At ExpressionEdits we are redefining the status quo of protein expression. Our proprietary platform developed at University of Cambridge improves transgene expression in mammalian systems. This has direct impact on recombinant protein yields and the quality and efficacy of DNA medicines.
If you think our technology can help you or you'd like to learn more about it, please get in touch:
ExpressionEdits Ltd is a company registered in England and Wales with company number 13517470.